Your browser doesn't support javascript.
loading
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.
Siller-Matula, Jolanta M; Specht, Simon; Kubica, Jacek; Alexopoulos, Dimitrios; De Caterina, Raffaele; Hobl, Eva-Luise; Jilma, Bernd; Christ, Günter; Lang, Irene M.
Afiliação
  • Siller-Matula JM; Department of Cardiology, Medical University of Vienna, Vienna, Austria. jolanta.siller-matula@meduniwien.ac.at.
  • Specht S; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Kubica J; Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Alexopoulos D; Department of Cardiology, Patras University Hospital, Patras, Greece.
  • De Caterina R; Institute of Cardiology, "G. d'Annunzio" University - Chieti-Pescara, Chieti, Italy.
  • Hobl EL; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Christ G; 5th Medical Department of Cardiology, Kaiser Franz Josef Hospital, Vienna, Austria.
  • Lang IM; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
Br J Clin Pharmacol ; 82(5): 1343-1350, 2016 11.
Article em En | MEDLINE | ID: mdl-27366874

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos Fab das Imunoglobulinas / Agregação Plaquetária / Interações Medicamentosas / Cloridrato de Prasugrel / Anticorpos Monoclonais / Morfina Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos Fab das Imunoglobulinas / Agregação Plaquetária / Interações Medicamentosas / Cloridrato de Prasugrel / Anticorpos Monoclonais / Morfina Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Áustria